Loading...
•
Dec 31, 2023
American Oncology Network Q4 2023 Earnings Report
Announced fourth quarter and full year 2023 financial results.
Key Takeaways
American Oncology Network (AON) reported a revenue of $324.2 million for Q4 2023, a 7.9% increase compared to Q4 2022. The increase was primarily driven by a 9.5% growth in patient encounters. However, the company experienced a net loss of $22.4 million, compared to a net income of $1.4 million in the same quarter of the previous year, mainly due to incremental accounts receivable reserves.
Q4 2023 revenue increased by 7.9% year-over-year to $324.2 million.
Patient encounters grew by 9.5% compared to the prior year quarter.
Net loss before non-controlling interest was $22.4 million, driven by incremental accounts receivable reserves.
Adjusted EBITDA was $5.0 million, a decrease from $8.0 million in the prior year quarter, primarily due to higher drug costs.
American Oncology Network
American Oncology Network
American Oncology Network Revenue by Segment
Revenue by Segment
Patient Service Revenue
CapyFin.comOther Revenue
CapyFin.com Forward Guidance
AON didn't provide specific forward guidance in this earnings report.
Revenue & Expenses
Visualization of income flow from segment revenue to net income